Maharashtra, India

Anand Jagannath Desai

This inventor holds 1 USPTO granted patent. Top assignee: Nicholas Piramal India Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anand Jagannath Desai. Retrieved from https://idiyas.com/inventor/anand-jagannath-desai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Anand Jagannath Desai

Introduction

Anand Jagannath Desai is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has led to advancements in the preparation of phenyl ethylamine compounds, which are essential in various medical applications.

Latest Patents

Anand Jagannath Desai holds a patent for the "Manufacture of phenyl ethylamine compounds, in particular venlafaxine." This patent describes a process for the preparation of hydroxy(cycloalkane/cyclokene) phenylethyl amine using an effective reduction process from its precursor cyanide. The process utilizes Raney Nickel as a catalyst, showcasing his innovative approach to chemical synthesis. He has 1 patent to his name.

Career Highlights

Desai is currently associated with Nicholas Piramal India Limited, a prominent player in the pharmaceutical industry. His role at the company has allowed him to apply his expertise in developing new compounds that can have a significant impact on healthcare.

Collaborations

Throughout his career, Anand Jagannath Desai has collaborated with esteemed colleagues such as Jagdish Chand Saigal and Rajender Pershad Gupta. These collaborations have further enriched his research and development efforts.

Conclusion

Anand Jagannath Desai's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patent and collaborations highlight his commitment to advancing medical science. His work continues to influence the development of important pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…